Although mechanism of action through which GLP-1 stimulates microglial function in regards to chronic inflammation remain unclear, several studies point to NF-κB activation achieved through DPP-IV inhibitors in rotenone induced rodent PD models. This evidence concerns the gene NFKB1 and Parkinson disease.